The TNBC Foundation welcomes a passionate advocate and seasoned nonprofit leader dedicated to strengthening support and driving progress for the TNBC community ...
Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the first clinical study results from its Oncodetect® molecular residual disease (MRD) ...
Triple negative breast cancer (TNBC) represents approximately 10-15% of all breast cancer diagnoses but accounts for a disproportionately high percentage of breast cancer deaths. What sets this ...
This article was medically reviewed by Lisa Richards, MSN, CNM, who offers health services at Ovia Health. Triple-negative breast cancer is an aggressive cancer that's primarily treated with ...